Peripheral blood fluorescence activated cell

Fig. 3 B-cell recovery and SPD in all responders (pivotal trial). Median B-cell counts in peripheral blood (as measured by CD 9 positivity on Fluorescence Activated Cell Sorter (FACS) analysis) drop to zero and start recovering by the sixth month. Tumor volume (as measured by SPD) for responders continues to decrease beyond nine months despite normalization of B-cell counts [38, 39]. This figure is used by permission from the copyright holders - Grillo-Lopez A] and Idee Pharmaceuticals.

---